Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 386
interventional 280
Observational 96
Registry 10

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 124
Procedure 30
Other 17
Drug|placebo 16
Drug|Other 14
Device 11
Biological 7
Biological|Drug 6
Drug|Procedure 5
Drug|Radiation 5
Radiation 5
Device|Drug 4
Diagnostic Test 4
Biological|Drug|Other 3
Biological|Drug|Procedure|Radiation 3
Drug|Other|Procedure 2
Drug|placebo|Radiation 2
Other|Procedure 2
Behavioral 1
Behavioral|Drug 1
Behavioral|Drug|Other|Procedure 1
Biological|Drug|Other|Procedure|Radiation 1
Biological|Other|Procedure|Radiation 1
Biological|Procedure 1
Biological|Radiation 1
Device|Drug|Other|Radiation 1
Device|Procedure 1
Device|Procedure|Radiation 1
Diagnostic Test|Drug 1
Diagnostic Test|Procedure 1
Dietary Supplement 1
Drug|Other|placebo 1
Drug|Other|Procedure|Radiation 1
Drug|Other|Radiation 1
Genetic 1
Other|Procedure|Radiation 1
placebo|Procedure 1
Procedure|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 121
China 25
Korea, Republic of 24
France 20
NA 9
Canada 7
Japan 4
Turkey 4
United States|Canada 4
Italy 3
Netherlands 3
United Kingdom 3
Brazil 2
Denmark 2
Egypt 2
India 2
Switzerland 2
United States|France 2
Australia|Austria|Belgium|Brazil|Bulgaria|Canada|China|Czechia|Denmark|Finland|Germany|Greece|India|Israel|Italy|Korea, Republic of|Poland|Russian Federation|Sweden|United Kingdom 1
Austria|Germany|Netherlands|Poland|Slovenia 1
Austria|Germany|Switzerland 1
Belgium|Denmark|France|Germany|Italy|Netherlands|Poland|Spain|United Kingdom 1
Belgium|Denmark|France|Norway|Spain|Sweden|Switzerland 1
China|Italy 1
Colombia 1
Cyprus 1
Estonia 1
Finland 1
Iran, Islamic Republic of 1
Israel|Italy|United States|Australia|Belgium|Canada|Denmark|France|Germany|Korea, Republic of|Poland|Romania|Russian Federation|Spain|Sweden|United Kingdom 1
Netherlands|Australia|Canada|Croatia|France|Hungary|Israel|Italy|Korea, Republic of|Poland|Romania|Russian Federation|Spain|Sweden 1
Poland 1
Spain 1
Taiwan 1
Thailand 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|Czechia|Denmark|France|Germany|Italy|Japan|Korea, Republic of|Poland|Portugal|Romania|Russian Federation|Spain|Sweden|Thailand|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Croatia|Czechia|France|Germany|Hong Kong|Hungary|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Poland|Romania|Russian Federation|Spain|Taiwan|Thailand|United Kingdom 1
United States|Argentina|France|Peru|Russian Federation|Ukraine 1
United States|Australia|Austria|Belgium|Brazil|Canada|Czechia|Denmark|France|Germany|Hungary|India|Italy|Korea, Republic of|Mexico|Netherlands|Poland|Portugal|Romania|Russian Federation|Serbia|Spain|Sweden|Switzerland 1
United States|Australia|Belgium|Brazil|Canada|China|Czechia|France|Germany|Greece|India|Israel|Italy|Japan|Korea, Republic of|Netherlands|Poland|Russian Federation|Spain|United Kingdom 1
United States|Australia|Belgium|China|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Netherlands|Poland|Singapore|Spain|Taiwan|United Kingdom 1
United States|Australia|Canada 1
United States|Australia|Canada|Denmark|France|Germany|Hong Kong|Israel|Italy|Japan|Korea, Republic of|Singapore|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Canada|Italy|Netherlands|Romania|Spain|Switzerland 1
United States|Australia|China|Singapore|Taiwan 1
United States|Australia|France|Italy|Poland|United Kingdom 1
United States|Austria|Belgium|Brazil|Canada|Chile|Denmark|France|Germany|Greece|India|Israel|Italy|Korea, Republic of|Netherlands|Peru|Poland|Portugal|Russian Federation|Saudi Arabia|Spain|Sweden|Switzerland|United Kingdom 1
United States|Austria|Belgium|Bulgaria|China|Denmark|France|Germany|Italy|Japan|Korea, Republic of|Netherlands|Poland|Russian Federation|Saudi Arabia|Spain|Sweden|United Kingdom 1
United States|Belgium|China|France|Germany|Hong Kong|Italy|Korea, Republic of|Netherlands|Singapore|Spain|Taiwan|United Kingdom 1
United States|Belgium|Denmark|Netherlands|Spain|United Kingdom 1
United States|Belgium|France|Germany|Greece|Italy|Korea, Republic of|Netherlands|Spain|United Kingdom 1
United States|Brazil|China|Czechia|Denmark|France|Italy|Japan|Poland|Russian Federation|Spain|Sweden 1
United States|Canada|China|Czech Republic|India|Italy|Poland|Spain|United Kingdom 1
United States|Canada|France|Germany|Hungary|Italy|Lebanon|Netherlands|Norway|Poland|Spain|Taiwan|Thailand|Turkey 1
United States|Canada|France|Germany|Italy 1
United States|Czechia|India|Israel|Italy|Netherlands|Poland|Russian Federation|United Kingdom 1
United States|France|Germany|Italy|Spain|United Kingdom 1
United States|France|Italy|Netherlands 1
United States|Puerto Rico 1

Sites per Study

Site_count Study_Count
1 167
2 13
3 12
4 4
5 8
6 5
7 6
8 1
9 7
10 5
11 2
12 3
13 2
15 3
16 1
17 1
19 3
21 1
22 2
23 2
24 1
25 1
26 2
27 1
28 1
33 2
34 1
35 1
42 1
43 2
50 1
61 1
66 1
81 1
84 1
86 1
92 1
96 1
114 1
130 1
140 1
143 1
145 1
154 1
155 1
253 1
508 1
938 1
1329 1

Phase

Phase Study_Count
Phase 2 108
N/A 80
Phase 1 29
Phase 3 22
Phase 1/Phase 2 20
Phase 4 9
Phase 2/Phase 3 8
Early Phase 1 4

Number of Arms

Number_of_Arms Count_of_Studies
1 131
2 97
3 15
4 14
5 4
8 1
9 1
37 1
NA 16

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 8.00 5.00 5.0000 3.0 1.0000 74.00 45.0000 10.00000
1st Qu. 9.50 43.75 16.0000 26.5 20.2500 89.75 125.5000 42.00000
Median 10.50 93.50 24.0000 87.5 36.0000 195.50 250.5000 56.00000
Mean 10.25 197.95 46.2069 204.5 119.7453 1574.50 278.8182 83.44444
3rd Qu. 11.25 153.75 44.0000 362.0 60.0000 557.00 412.7500 116.00000
Max. 12.00 5750.00 216.0000 970.0 6452.0000 10838.00 780.0000 250.00000

Trial Group Type

group_type Group_Count
Experimental 366
Active Comparator 69
Placebo Comparator 27
No Intervention 20
NA 16
Other 15
Sham Comparator 3

Intervention Model

intervention_model Study_Count
Single Group Assignment 142
Parallel Assignment 115
Crossover Assignment 8
Sequential Assignment 8
NA 4
Factorial Assignment 3

Primary Purpose

primary_purpose Study_Count
Treatment 211
Diagnostic 31
Supportive Care 11
Prevention 10
Other 8
NA 4
Basic Science 2
Screening 2
Health Services Research 1

Observational Studies

Studies by Country

Country Study_Count
United States 27
Korea, Republic of 7
NA 7
Italy 6
France 5
United Kingdom 5
Canada 4
Taiwan 4
Turkey 4
Spain 3
China 2
Germany 2
Japan 2
Kazakhstan 2
Belarus 1
Belgium|France|Germany|Italy|Luxembourg|Netherlands|Spain|United Kingdom 1
Denmark 1
Egypt 1
Germany|Italy|Portugal|Spain 1
Greece|Jordan|Turkey 1
Netherlands 1
Norway 1
Poland 1
Romania 1
Slovenia 1
Sweden 1
Switzerland 1
Ukraine 1
United States|Algeria|Argentina|Brazil|Egypt|France|Germany|Greece|India|Japan|Lebanon|Mexico|Netherlands|Philippines|Russian Federation|Saudi Arabia|Spain|Taiwan|Turkey 1
United States|Israel 1

Sites per Study

Site_count Study_Count
1 83
2 6
3 1
5 1
7 1
9 1
16 1
30 1
34 1

Enrollment Metrics

Measure Observational
Min 1.00
1st Qu 50.00
Median 128.00
Mean 11759.94
3rd Qu 425.50
Max 815000.00

Observation Model

observational_model Study_Count
Cohort 49
Case-Only 12
NA 10
Case-Control 7
Case Control 7
Other 6
Defined Population, Natural History 2
Ecologic or Community 1
Family-Based 1
Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 58
Retrospective 21
Cross-Sectional 7
Other 3
Cross-Sectional, Prospective 2
NA 2
Longitudinal, Prospective 1
Longitudinal, Retrospective 1
Longitudinal, Retrospective/Prospective 1

Registries

Studies by Country

Country Study_Count
United States 4
Belgium 1
France 1
Ireland|United Kingdom 1
NA 1
Taiwan 1
Thailand 1

Sites per Study

Site_count Study_Count
1 7
8 1
12 1
75 1

Enrollment Metrics

Measure Registries
Min 10.0
1st Qu 80.0
Median 598.5
Mean 101315.0
3rd Qu 2750.0
Max 999999.0

Registry Model

observational_model Study_Count
Cohort 7
Case-Only 3

Time Perspective

time_perspective Study_Count
Prospective 8
Other 2

Follow-up

target_duration Study_Count
10 Years 1
12 Months 1
13 Years 1
15 Years 1
16 Months 1
3 Years 1
30 Years 1
52 Weeks 1
6 Months 1
80 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT01882816 Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01882816 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-06-30
NCT01141309 Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer https://ClinicalTrials.gov/show/NCT01141309 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-06-30
NCT04211337 A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT04211337 Recruiting Eli Lilly and Company 2023-02-17
NCT04129411 Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation https://ClinicalTrials.gov/show/NCT04129411 Recruiting Mayo Clinic 2022-03-31
NCT03469011 A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer. https://ClinicalTrials.gov/show/NCT03469011 Recruiting AHS Cancer Control Alberta 2020-12-31
NCT03463889 Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer https://ClinicalTrials.gov/show/NCT03463889 Recruiting University of California, San Francisco 2021-12-31
NCT03359668 CT Detection of Metastatic Lymphadenopathy in Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT03359668 Completed University Health Network, Toronto 2017-04-20
NCT03377829 A Multicenter Trial of PLA vs. Surgery for Treating PTMC https://ClinicalTrials.gov/show/NCT03377829 Recruiting Ruijin Hospital 2020-12-31
NCT03360890 Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors https://ClinicalTrials.gov/show/NCT03360890 Recruiting University of Chicago 2020-06-30
NCT03274258 Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma https://ClinicalTrials.gov/show/NCT03274258 Recruiting M.D. Anderson Cancer Center 2020-07-01
NCT03246958 Nivolumab Plus Ipilimumab in Thyroid Cancer https://ClinicalTrials.gov/show/NCT03246958 Recruiting Dana-Farber Cancer Institute 2021-03-31
NCT03244956 Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03244956 Recruiting Gustave Roussy, Cancer Campus, Grand Paris 2022-12-31
NCT03215095 RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers https://ClinicalTrials.gov/show/NCT03215095 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-07-31
NCT03211117 Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer https://ClinicalTrials.gov/show/NCT03211117 Completed Mayo Clinic 2018-02-12
NCT03181100 Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03181100 Recruiting M.D. Anderson Cancer Center 2023-07-27
NCT03176485 Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors https://ClinicalTrials.gov/show/NCT03176485 Completed University of Arizona 2018-11-01
NCT03174925 Ultrasound Elastography in Imaging Patients With Thyroid Nodules https://ClinicalTrials.gov/show/NCT03174925 Active, not recruiting Stanford University 2020-08-15
NCT03167385 Phase 2 Trial of Apatinib Mesylate in Locally Advanced/Metastatic Differentiated Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT03167385 Recruiting Tianjin Medical University Cancer Institute and Hospital 2019-01-31
NCT03162627 Selumetinib and Olaparib in Solid Tumors https://ClinicalTrials.gov/show/NCT03162627 Recruiting M.D. Anderson Cancer Center 2026-08-31
NCT03139747 UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone https://ClinicalTrials.gov/show/NCT03139747 Completed Abramson Cancer Center of the University of Pennsylvania 2019-10-03
NCT03127098 QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer https://ClinicalTrials.gov/show/NCT03127098 Completed NantCell, Inc. 2017-12-07
NCT03122496 Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer https://ClinicalTrials.gov/show/NCT03122496 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-04-30
NCT03109847 Metformin Hydrochloride in Mitigating Side Effects of Radioactive Iodine Treatment in Patients With Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03109847 Recruiting Thomas Jefferson University 2021-06-08
NCT03099356 Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03099356 Recruiting University of Michigan Rogel Cancer Center 2022-05-12
NCT03093909 Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases https://ClinicalTrials.gov/show/NCT03093909 Recruiting M.D. Anderson Cancer Center 2021-11-30
NCT03085056 Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer https://ClinicalTrials.gov/show/NCT03085056 Recruiting Memorial Sloan Kettering Cancer Center 2021-09-30
NCT03072160 Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT03072160 Completed National Institutes of Health Clinical Center (CC) 2019-11-22
NCT03048877 Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03048877 Active, not recruiting Peking Union Medical College Hospital 2020-07-31
NCT03037385 Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03037385 Recruiting Blueprint Medicines Corporation 2021-12-31
NCT03024151 The Effects of T4 Versus T4/T3 on Psychological Distress After Total Thyroidectomy in Thyroid Cancer Patients https://ClinicalTrials.gov/show/NCT03024151 Completed Inje University 2017-11-30
NCT03012620 Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types https://ClinicalTrials.gov/show/NCT03012620 Recruiting UNICANCER 2023-01-31
NCT02988817 Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors https://ClinicalTrials.gov/show/NCT02988817 Recruiting Genmab 2021-02-28
NCT02973997 Lenvatinib and Pembrolizumab in DTC https://ClinicalTrials.gov/show/NCT02973997 Active, not recruiting Academic and Community Cancer Research United 2021-10-08
NCT02966093 A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China https://ClinicalTrials.gov/show/NCT02966093 Active, not recruiting Eisai Inc. 2019-07-31
NCT02947035 Molecular Testing to Direct Extent of Initial Thyroid Surgery https://ClinicalTrials.gov/show/NCT02947035 Recruiting University of Pittsburgh 2022-02-01
NCT02878044 Shared Decision Making in Patients With Thyroid Nodules https://ClinicalTrials.gov/show/NCT02878044 Recruiting Mayo Clinic 2021-04-30
NCT02870569 Phase 2 Trial of Donafenib in 131I-Refractory Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT02870569 Completed Suzhou Zelgen Biopharmaceuticals Co.,Ltd 2018-07-02
NCT02856347 Prospective Study Evaluating the Medullary Thyroid Cancer Management’s Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin https://ClinicalTrials.gov/show/NCT02856347 Recruiting Institut Claudius Regaud 2021-04-30
NCT02839655 Prospective Study Assessing Thyroidectomy Using Robot https://ClinicalTrials.gov/show/NCT02839655 Active, not recruiting Gustave Roussy, Cancer Campus, Grand Paris 2018-05-15
NCT02826746 Effect of Intravenous Magnesium on Postoperative Sore Throat After Thyroidectomy https://ClinicalTrials.gov/show/NCT02826746 Completed Ajou University School of Medicine 2019-03-31
NCT02758158 Tri-modal Imaging Instrument for Thyroid Cancer https://ClinicalTrials.gov/show/NCT02758158 Completed University Health Network, Toronto 2017-02-28
NCT02747888 Hereditary Risk Factors for Thyroid Cancer https://ClinicalTrials.gov/show/NCT02747888 Recruiting Dana-Farber Cancer Institute 2021-03-01
NCT02731352 Study of Apatinib in Patients With Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT02731352 Active, not recruiting Peking Union Medical College Hospital 2020-02-27
NCT02726503 Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer https://ClinicalTrials.gov/show/NCT02726503 Completed Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 2020-02-25
NCT02724176 Potential Role for Carbon Nanoparticles to Guide Central Neck Dissection in Patients With Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT02724176 Completed Beijing Cancer Hospital 2016-01-31
NCT02713269 Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord https://ClinicalTrials.gov/show/NCT02713269 Recruiting M.D. Anderson Cancer Center 2022-07-01
NCT02688608 Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT02688608 Recruiting University of Texas Southwestern Medical Center 2020-10-31
NCT02657551 A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT02657551 Recruiting Dana-Farber Cancer Institute 2020-12-31
NCT02614495 Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT02614495 Completed Hutchison Medipharma Limited 2018-09-30
NCT02609685 Active Surveillance of Papillary Thyroid Microcarcinoma https://ClinicalTrials.gov/show/NCT02609685 Recruiting Cedars-Sinai Medical Center 2030-12-31
NCT02602717 The Evaluation of the Diagnostic Properties of Intra-operative In-situ Thyroglobin Levels of Cervical Lymph Nodes, in the Discrimination Between Benign and Malignant Lymph Nodes in Thyroid Cancer: a Prospective Multicentre Study. https://ClinicalTrials.gov/show/NCT02602717 Recruiting Assistance Publique Hopitaux De Marseille 2017-05-17
NCT02592356 Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer https://ClinicalTrials.gov/show/NCT02592356 Active, not recruiting M.D. Anderson Cancer Center 2020-11-30
NCT02586350 Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031) https://ClinicalTrials.gov/show/NCT02586350 Completed Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 2018-09-30
NCT02586337 Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032) https://ClinicalTrials.gov/show/NCT02586337 Active, not recruiting Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 2019-12-31
NCT02834013 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors https://ClinicalTrials.gov/show/NCT02834013 Recruiting National Cancer Institute (NCI) 2021-08-31
NCT01896479 A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01896479 Active, not recruiting Exelixis 2020-09-30
NCT02465060 Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) https://ClinicalTrials.gov/show/NCT02465060 Recruiting National Cancer Institute (NCI) 2022-06-30
NCT02561533 Detection of BRAF Mutation on FNAB From Papillary Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT02561533 Completed University of Aarhus 2017-07-31
NCT03196518 Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer https://ClinicalTrials.gov/show/NCT03196518 Recruiting Memorial Sloan Kettering Cancer Center 2022-06-30
NCT02515084 Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT02515084 Completed Centre Henri Becquerel 2015-07-31
NCT02464696 Early Non Invasive Ventilation and Hematological Malignancies https://ClinicalTrials.gov/show/NCT02464696 Recruiting M.D. Anderson Cancer Center 2020-10-01
NCT02456701 Enhancing Radioiodine Incorporation Into BRAF Mutant Thyroid Cancers With the Combination of Vemurafenib and KTN3379 https://ClinicalTrials.gov/show/NCT02456701 Completed Celldex Therapeutics 2016-10-13
NCT02418390 The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT02418390 Recruiting Seoul National University Hospital 2022-02-28
NCT02418247 Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT02418247 Active, not recruiting National Cancer Center, Korea 2017-12-31
NCT02412150 Effect of Dexmedetomidine After Thyroidectomy https://ClinicalTrials.gov/show/NCT02412150 Recruiting Chosun University Hospital 2020-12-30
NCT02408887 Total Thyroidectomy With and Without Prophylactic Central Neck Lymph Node Dissection in People With Low-risk Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT02408887 Completed National Institutes of Health Clinical Center (CC) 2019-05-07
NCT02404441 Phase I/II Study of PDR001 in Patients With Advanced Malignancies https://ClinicalTrials.gov/show/NCT02404441 Active, not recruiting Novartis 2020-07-01
NCT02393690 Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT02393690 Active, not recruiting Academic and Community Cancer Research United 2021-02-01
NCT02390934 Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT02390934 Completed Gustave Roussy, Cancer Campus, Grand Paris 2019-04-02
NCT02383927 Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations https://ClinicalTrials.gov/show/NCT02383927 Active, not recruiting Kura Oncology, Inc. 2021-01-15
NCT02363647 Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer https://ClinicalTrials.gov/show/NCT02363647 Enrolling by invitation Icahn School of Medicine at Mount Sinai 2020-01-31
NCT02304757 99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Decreased Bone Mineral Density https://ClinicalTrials.gov/show/NCT02304757 Recruiting Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 2020-06-30
NCT02278198 Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123 https://ClinicalTrials.gov/show/NCT02278198 Completed University of Colorado, Denver 2019-09-20
NCT02244463 A Phase II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer https://ClinicalTrials.gov/show/NCT02244463 Recruiting Dana-Farber Cancer Institute 2020-12-31
NCT02223052 Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies https://ClinicalTrials.gov/show/NCT02223052 Completed Celgene 2018-06-11
NCT02208544 FDG-PET/CT in Evaluation of Cytological Indeterminate Thyroid Nodules to Prevent Unnecessary Surgery (EfFECTS) https://ClinicalTrials.gov/show/NCT02208544 Active, not recruiting Radboud University 2020-07-01
NCT02205801 Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy https://ClinicalTrials.gov/show/NCT02205801 Completed University of Chicago 2017-02-10
NCT02156362 Determination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis) https://ClinicalTrials.gov/show/NCT02156362 Recruiting Hospices Civils de Lyon 2023-05-31
NCT02152995 Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT02152995 Recruiting National Cancer Institute (NCI) 2020-12-31
NCT02152137 Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer https://ClinicalTrials.gov/show/NCT02152137 Active, not recruiting Alliance for Clinical Trials in Oncology 2019-02-27
NCT02145143 Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study https://ClinicalTrials.gov/show/NCT02145143 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-05-31
NCT02143726 Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer https://ClinicalTrials.gov/show/NCT02143726 Active, not recruiting Alliance for Clinical Trials in Oncology 2020-08-31
NCT02138214 Central Neck Dissection in Patients With Clinical Node Negative Thyroid Cancer https://ClinicalTrials.gov/show/NCT02138214 Active, not recruiting University of Wisconsin, Madison 2019-10-30
NCT02114658 Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients https://ClinicalTrials.gov/show/NCT02114658 Completed Bayer 2015-02-23
NCT02088645 177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer. https://ClinicalTrials.gov/show/NCT02088645 Recruiting University Hospital, Basel, Switzerland 2021-12-31
NCT02084732 Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study https://ClinicalTrials.gov/show/NCT02084732 Completed Instituto Nacional de Cancerologia, Columbia 2019-11-01
NCT01308320 Dose-dependent Effect of Fentanyl on Cough Attenuation During Emergence From General Anaesthesia https://ClinicalTrials.gov/show/NCT01308320 Completed Yonsei University 2010-07-31
NCT01298323 Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment https://ClinicalTrials.gov/show/NCT01298323 Active, not recruiting Sanofi 2013-04-30
NCT01292044 The Role of Elastography in the Diagnosis of Thyroid Nodules https://ClinicalTrials.gov/show/NCT01292044 Completed Centre Hospitalier Universitaire de Nīmes 2014-08-31
NCT01286753 A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation https://ClinicalTrials.gov/show/NCT01286753 Completed Hoffmann-La Roche 2014-11-30
NCT01270321 Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01270321 Completed Emory University 2019-02-28
NCT02055989 A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx https://ClinicalTrials.gov/show/NCT02055989 Completed Royal Marsden NHS Foundation Trust 2011-12-31
NCT02041260 A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting https://ClinicalTrials.gov/show/NCT02041260 Active, not recruiting Abramson Cancer Center of the University of Pennsylvania 2020-03-31
NCT02018276 Effect of Perioperative Intravenous Lidocaine Infusion and Magnesium Infusion on the Functional Recovery After General Anesthesia in the Patients Undergoing Thyroid Surgery https://ClinicalTrials.gov/show/NCT02018276 Completed Yonsei University 2014-10-31
NCT02012686 The Effect of Transcutaneous Electrical Nerve Stimulation on Posterior Neck Pain After Thyroidectomy https://ClinicalTrials.gov/show/NCT02012686 Completed Yonsei University 2014-01-31
NCT01964144 An Open-label, Multicenter, Phase II Study of Dovitinib in Advanced Thyroid Cancer https://ClinicalTrials.gov/show/NCT01964144 Completed Yonsei University 2014-10-31
NCT01947023 Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT01947023 Active, not recruiting National Cancer Institute (NCI) 2020-07-01
NCT01927887 Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study https://ClinicalTrials.gov/show/NCT01927887 Completed Massachusetts General Hospital 2015-04-30
NCT01907997 Effects of Systemic Lidocaine on Postoperative Quality of Recovery After Robot-assisted Thyroidectomy https://ClinicalTrials.gov/show/NCT01907997 Completed Yonsei University 2015-03-31
NCT01856920 QUILT-3.006 for Recurrent Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01856920 Active, not recruiting NantCell, Inc. 2019-12-31
NCT01840332 Method of Endogenous TSH Stimulation in the Follow-up of Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT01840332 Completed University of Tartu 2014-02-28
NCT01837745 Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients? https://ClinicalTrials.gov/show/NCT01837745 Recruiting Gustave Roussy, Cancer Campus, Grand Paris 2020-04-30
NCT01833650 The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer https://ClinicalTrials.gov/show/NCT01833650 Completed Cyprus University of Technology 2018-08-31
NCT01813136 Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT01813136 Completed Centre Leon Berard 2019-01-31
NCT01811212 Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer https://ClinicalTrials.gov/show/NCT01811212 Completed National Cancer Institute (NCI) 2015-07-13
NCT01788982 Nintedanib(BIBF1120) in Thyroid Cancer https://ClinicalTrials.gov/show/NCT01788982 Active, not recruiting European Organisation for Research and Treatment of Cancer - EORTC 2019-10-31
NCT01776385 The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma https://ClinicalTrials.gov/show/NCT01776385 Completed Centre Hospitalier Universitaire de Nice 2017-12-31
NCT01730638 ImmunoTEP for Patients With Medullary Thyroid Carcinoma. https://ClinicalTrials.gov/show/NCT01730638 Completed Nantes University Hospital 2016-12-31
NCT01728623 A Study of E7080 in Subjects With Advanced Thyroid Cancer https://ClinicalTrials.gov/show/NCT01728623 Completed Eisai Inc. 2015-07-31
NCT01723202 Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer https://ClinicalTrials.gov/show/NCT01723202 Active, not recruiting Ohio State University Comprehensive Cancer Center 2020-12-31
NCT01709435 Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT01709435 Completed National Cancer Institute (NCI) 2018-12-31
NCT01709292 Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer https://ClinicalTrials.gov/show/NCT01709292 Active, not recruiting M.D. Anderson Cancer Center 2020-11-30
NCT01661179 Evaluate the Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT01661179 Completed Sanofi 2013-12-31
NCT01655719 Pioglitazone in Thyroid Cancers https://ClinicalTrials.gov/show/NCT01655719 Completed University of Michigan 2017-03-31
NCT01638533 Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction https://ClinicalTrials.gov/show/NCT01638533 Active, not recruiting National Cancer Institute (NCI) 2018-11-29
NCT01631552 Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers https://ClinicalTrials.gov/show/NCT01631552 Active, not recruiting Immunomedics, Inc. 2020-06-30
NCT01625520 SOM230 Alone or in Combination With RAD001 in Patients With Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01625520 Completed Federico II University 2016-03-31
NCT01617694 Comparison Between Remifentanil Target-controlled Infusion and Dexmedetomidine Bolus Administration for Smooth Emergence From General Sevoflurane Anesthesia https://ClinicalTrials.gov/show/NCT01617694 Completed Yonsei University 2011-11-30
NCT01616316 Efficacy of Subfascial Approach in Thyroidectomy to Quality of Life in Thyroid Disease Patients https://ClinicalTrials.gov/show/NCT01616316 Completed Samsung Medical Center 2012-01-31
NCT01552434 Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease https://ClinicalTrials.gov/show/NCT01552434 Recruiting M.D. Anderson Cancer Center 2020-03-31
NCT01534897 Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436 https://ClinicalTrials.gov/show/NCT01534897 Completed Massachusetts General Hospital 2014-03-31
NCT01510002 Prophylactic Central Neck Dissection for Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01510002 Completed Jagiellonian University 2011-09-30
NCT01502410 Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer https://ClinicalTrials.gov/show/NCT01502410 Completed National Cancer Institute (NCI) 2014-06-30
NCT01496313 To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01496313 Active, not recruiting Sanofi 2014-04-30
NCT01438554 Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT01438554 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2016-04-30
NCT01437254 To Compare Safety and the General Imaging Pattern of Cyclotron Produced Technetium vs. Generator Produced Technetium in Patients With Thyroid Cancer https://ClinicalTrials.gov/show/NCT01437254 Completed AHS Cancer Control Alberta 2012-04-30
NCT01413113 Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT01413113 Completed University of Washington 2013-11-30
NCT01398085 IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients https://ClinicalTrials.gov/show/NCT01398085 Recruiting University College, London 2020-11-30
NCT01341886 Effect of Metformin on Decrement in Levothyroxin Dose Required for Thyroid Stimulating Hormone (TSH) Suppression in Patients With Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT01341886 Completed Mashhad University of Medical Sciences 2011-04-30
NCT01325857 Analgesic Efficacy of Bilateral Superficial Cervical Plexus Block in Robot-assisted Endoscopic Thyroidectomy Using a Transaxillary Approach https://ClinicalTrials.gov/show/NCT01325857 Completed Yonsei University 2012-02-29
NCT01321554 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC) https://ClinicalTrials.gov/show/NCT01321554 Completed Eisai Inc. 2013-11-15
NCT04425512 Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Thyroid Malignancy https://ClinicalTrials.gov/show/NCT04425512 Completed Kahramanmaras Sutcu Imam University 2019-11-01
NCT04420689 A Study of ALM-488 to Highlight Nerves in Patients Undergoing Head & Neck Surgery https://ClinicalTrials.gov/show/NCT04420689 Recruiting Alume Biosciences, Inc. 2020-12-31
NCT04410601 Post-thyroidectomy Dysphagia: An International Multicentric CONSORT - Compatible RCT https://ClinicalTrials.gov/show/NCT04410601 Recruiting Umraniye Education and Research Hospital 2021-06-30
NCT04336696 Is Routine Dissection of Central Lymph Node Necessary for Papillary Thyroid Carcinoma, T1-2 N0? https://ClinicalTrials.gov/show/NCT04336696 Recruiting Zagazig University 2020-04-03
NCT04312087 Lateral Neck Lymph Node Mapping in Thyroid Cancer https://ClinicalTrials.gov/show/NCT04312087 Recruiting Fudan University 2021-08-01
NCT04309136 Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer https://ClinicalTrials.gov/show/NCT04309136 Recruiting Fudan University 2021-06-01
NCT04290663 Systematic Radioiodine Administration (3.7 GBq I131 After rhTSH) Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up https://ClinicalTrials.gov/show/NCT04290663 Recruiting Centre Francois Baclesse 2026-02-28
NCT04281875 Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy. https://ClinicalTrials.gov/show/NCT04281875 Recruiting Vanderbilt-Ingram Cancer Center 2021-03-31
NCT04280081 A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation https://ClinicalTrials.gov/show/NCT04280081 Recruiting Eli Lilly and Company 2021-05-31
NCT04248166 Thyroid Cancer and Photoacoustic Imaging https://ClinicalTrials.gov/show/NCT04248166 Recruiting Seoul St. Mary’s Hospital 2020-06-30
NCT04238624 Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer https://ClinicalTrials.gov/show/NCT04238624 Recruiting Memorial Sloan Kettering Cancer Center 2022-06-20
NCT04180007 Study of Neoadjuvant Regimen for Radioactive Iodine Treatment of Metastatic and Advanced Differentiated Thyroid Cancers https://ClinicalTrials.gov/show/NCT04180007 Recruiting Nanjing First Hospital, Nanjing Medical University 2020-04-10
NCT04129281 Active Surveillance Versus Surgery in Thyroid Papillary Microcarcinoma https://ClinicalTrials.gov/show/NCT04129281 Recruiting National Cancer Institute, Naples 2022-01-23
NCT04104529 Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department https://ClinicalTrials.gov/show/NCT04104529 Recruiting Institut du Cancer de Montpellier - Val d’Aurelle 2024-10-31
NCT03268785 Intra-operative Rapid Identification of Lymph Node and Parathyroid https://ClinicalTrials.gov/show/NCT03268785 Recruiting Xijing Hospital 2018-08-01
NCT03986593 Cryoablation of Bone Metastases From Endocrine Tumors https://ClinicalTrials.gov/show/NCT03986593 Recruiting Instituto do Cancer do Estado de São Paulo 2021-06-15
NCT03969108 Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment https://ClinicalTrials.gov/show/NCT03969108 Completed University Health Network, Toronto 2019-11-12
NCT03914300 Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03914300 Recruiting National Cancer Institute (NCI) 2021-01-15
NCT03899792 A Study of Oral LOXO-292 in Pediatric Patients With Advanced Solid or Primary Central Nervous System Tumors https://ClinicalTrials.gov/show/NCT03899792 Recruiting Loxo Oncology, Inc. 2021-11-30
NCT03892993 Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers https://ClinicalTrials.gov/show/NCT03892993 Recruiting M.D. Anderson Cancer Center 2020-07-31
NCT03845647 Significance of Contralateral Central Lymph Node Dissection in Unilateral cN0 Differentiated Thyroid Carcinoma. https://ClinicalTrials.gov/show/NCT03845647 Recruiting Fifth Affiliated Hospital, Sun Yat-Sen University 2020-01-28
NCT03841617 The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03841617 Recruiting National Institutes of Health Clinical Center (CC) 2024-02-01
NCT03830242 Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer. https://ClinicalTrials.gov/show/NCT03830242 Recruiting Fifth Affiliated Hospital, Sun Yat-Sen University 2019-12-31
NCT03826680 Modified Cormack Lehane Scores Evaluated by Laryngoscopy During Awake Versus Under General Anesthesia https://ClinicalTrials.gov/show/NCT03826680 Recruiting Istanbul University 2020-06-30
NCT03808779 A Multicenter Trial of Radiofrequency Ablation vs. Surgery as Treatment of Papillary Thyroid Microcarcinoma. https://ClinicalTrials.gov/show/NCT03808779 Recruiting Second Affiliated Hospital, School of Medicine, Zhejiang University 2024-02-01
NCT03794375 Primary Care Transfer for Thyroid Cancer Patients https://ClinicalTrials.gov/show/NCT03794375 Enrolling by invitation Hospital de Clinicas de Porto Alegre 2020-12-31
NCT03757637 Compare the Effects of NLSCP and Interactive ICT Supported HAP on Differentiate Diagnosed Thyroid Cancer Patients https://ClinicalTrials.gov/show/NCT03757637 Recruiting National Taiwan University Hospital 2021-07-31
NCT03753919 Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY Trial https://ClinicalTrials.gov/show/NCT03753919 Recruiting Grupo Espanol de Tumores Neuroendocrinos 2020-12-31
NCT03732495 Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas https://ClinicalTrials.gov/show/NCT03732495 Recruiting Centre Leon Berard 2021-12-15
NCT03690388 A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior VEGFR-targeted Therapy https://ClinicalTrials.gov/show/NCT03690388 Recruiting Exelixis 2020-07-31
NCT03680222 Effect of Reversed Tracking Method for Identification of EBSLN in Thyroid Surgery https://ClinicalTrials.gov/show/NCT03680222 Recruiting Fujian Medical University 2019-09-30
NCT03647657 177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT03647657 Recruiting University Hospital, Basel, Switzerland 2020-06-30
NCT03647358 Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT03647358 Recruiting Memorial Sloan Kettering Cancer Center 2022-08-31
NCT03630120 Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer https://ClinicalTrials.gov/show/NCT03630120 Active, not recruiting H. Lee Moffitt Cancer Center and Research Institute 2020-12-31
NCT03602495 Donafenib in 131I-Refractory Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03602495 Recruiting Suzhou Zelgen Biopharmaceuticals Co.,Ltd 2020-12-31
NCT03577951 Comparing the Establishment of Operation Space Between High Position and Low Position in Endoscopic Thyroid Surgery https://ClinicalTrials.gov/show/NCT03577951 Recruiting Fujian Medical University 2018-08-31
NCT03573960 A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03573960 Recruiting Eisai Inc. 2020-06-01
NCT03547648 Effect of Three Different Peak Airway Pressures on Determining Intraoperative Bleeding in Thryroidectomies https://ClinicalTrials.gov/show/NCT03547648 Completed Istanbul University 2018-11-16
NCT03530033 Lidocaine Reduces Muscle Tremor is Beneficial for Intraoperative Recurrent Laryngeal Nerve Monitoring https://ClinicalTrials.gov/show/NCT03530033 Recruiting Fujian Medical University 2018-10-31
NCT03517579 Personalized Treatment in Thyroid Disorders https://ClinicalTrials.gov/show/NCT03517579 Recruiting Johns Hopkins University 2020-10-15
NCT03506048 Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03506048 Recruiting Emory University 2021-01-31
NCT03484416 Routine Calcium for Preventing Hypocalcemia https://ClinicalTrials.gov/show/NCT03484416 Completed Ewha Womans University Mokdong Hospital 2017-05-30
NCT03470259 Precision Thyroid Cancer Surgery With Molecular Fluorescent Guided Imaging https://ClinicalTrials.gov/show/NCT03470259 Completed University Medical Center Groningen 2019-12-31
NCT03469310 Minimizing Narcotic Analgesics After Endocrine Surgery https://ClinicalTrials.gov/show/NCT03469310 Active, not recruiting Doctors Hospital at Renaissance 2019-12-21
NCT02112370 Efficacy of Ropivacaine (With Epinephrine) in BABA Endoscopic and Robotic Thyroidectomy https://ClinicalTrials.gov/show/NCT02112370 Completed Seoul National University Hospital 2016-05-31
NCT03454477 Comparison Between Robotic, Endoscopic and Traditional Open Surgery in Thyroidectomy https://ClinicalTrials.gov/show/NCT03454477 Recruiting Fujian Medical University 2018-10-01
NCT03454464 Evaluation of Central Compartment Dissection Without Thyroidectomy https://ClinicalTrials.gov/show/NCT03454464 Recruiting Fujian Medical University 2018-12-31
NCT03435952 Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT https://ClinicalTrials.gov/show/NCT03435952 Recruiting M.D. Anderson Cancer Center 2021-10-31
NCT03432299 Radiofrequency Ablation of Low Risk Papillary Thyroid Microcarcinoma https://ClinicalTrials.gov/show/NCT03432299 Recruiting Seoul National University Hospital 2020-11-27
NCT03420963 Ex-Vivo Expanded Allogeneic NK Cells For The Treatment Of Pediatric Solid Tumors https://ClinicalTrials.gov/show/NCT03420963 Recruiting M.D. Anderson Cancer Center 2022-12-01
NCT03411187 Study on the Application of Convenient Foot-control Exhaust Method in Endoscopic Thyroidectomy https://ClinicalTrials.gov/show/NCT03411187 Recruiting Fujian Medical University 2018-06-30
NCT01263951 Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone https://ClinicalTrials.gov/show/NCT01263951 Completed Abramson Cancer Center of the University of Pennsylvania 2018-12-31
NCT04462471 Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers https://ClinicalTrials.gov/show/NCT04462471 Recruiting Memorial Sloan Kettering Cancer Center 2022-06-30
NCT01240590 A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) https://ClinicalTrials.gov/show/NCT01240590 Completed National Institutes of Health Clinical Center (CC) 2015-08-31
NCT01236547 Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer https://ClinicalTrials.gov/show/NCT01236547 Active, not recruiting National Cancer Institute (NCI) 2020-03-09
NCT01229865 Safety and Efficacy of VB-111 in Subjects With Advanced Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT01229865 Completed Vascular Biogenics Ltd. operating as VBL Therapeutics 2014-10-31
NCT01226914 A Trial Comparing Wound Drainage and Post-operative Complications With and Without the Use of EVICELâ„¢ Fibrin Sealant in Thyroidectomy https://ClinicalTrials.gov/show/NCT01226914 Completed Medical University of South Carolina 2014-07-31
NCT01208051 Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer https://ClinicalTrials.gov/show/NCT01208051 Active, not recruiting National Cancer Institute (NCI) 2020-02-01
NCT01182285 A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin https://ClinicalTrials.gov/show/NCT01182285 Completed National Institutes of Health Clinical Center (CC) 2015-09-28
NCT01173289 Study of External Beam Radiotherapy to Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT01173289 Completed National Cancer Center, Korea 2015-08-31
NCT01164176 Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT01164176 Completed Yonsei University 2014-10-31
NCT01150318 Testicular Function After Iodine 131 Therapy in Papillary Carcinoma Patients https://ClinicalTrials.gov/show/NCT01150318 Completed Assistance Publique - Hôpitaux de Paris 2010-06-30
NCT01137097 Lateral Neck Sentinel Lymph Node Biopsy(LSLNB)in PTC https://ClinicalTrials.gov/show/NCT01137097 Completed Samsung Medical Center 2011-01-31
NCT01126060 Efficacy of Fibrin Sealant to Reduce the Amount of Post-thyroidectomy Drain https://ClinicalTrials.gov/show/NCT01126060 Completed Samsung Medical Center 2011-01-31
NCT01103557 Prophylactic Selective Lateral Neck Dissection in Patients With Papillary Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT01103557 Completed Pusan National University Hospital NA
NCT01100619 A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors https://ClinicalTrials.gov/show/NCT01100619 Completed Exelixis 2012-08-31
NCT01083550 Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01083550 Completed University Health Network, Toronto 2016-11-30
NCT03871387 The Effects of Deep Neuromuscular Blockade During Robot-assisted Transaxillary Thyroidectomy on Postoperative Pain and Sensory Change https://ClinicalTrials.gov/show/NCT03871387 Completed Yonsei University 2020-02-24
NCT01025453 Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer https://ClinicalTrials.gov/show/NCT01025453 Completed Memorial Sloan Kettering Cancer Center 2018-01-16
NCT01013597 Trial of LBH589 in Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT01013597 Completed University of Wisconsin, Madison 2013-08-31
NCT00984282 Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT00984282 Completed Bayer 2012-08-31
NCT00970359 Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244 https://ClinicalTrials.gov/show/NCT00970359 Completed Memorial Sloan Kettering Cancer Center 2013-04-30
NCT00936858 RAD001 for Patients With Radioiodine Refractory Thyroid Cancer https://ClinicalTrials.gov/show/NCT00936858 Completed Dana-Farber Cancer Institute 2020-02-27
NCT00887107 Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT00887107 Completed Leiden University Medical Center NA
NCT04424485 Near-infrared Fluorescence With Indocyanine Green for Identification of Sentinels and Parathyroids During Thyroidectomy https://ClinicalTrials.gov/show/NCT04424485 Recruiting Umraniye Education and Research Hospital 2021-06-01
NCT03375931 The Effects of Preoperative Prayer on Postoperative Quality of Recovery in Patients Undergoing Thyroidectomy https://ClinicalTrials.gov/show/NCT03375931 Recruiting Yonsei University 2020-05-31
NCT01876784 Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT01876784 Active, not recruiting Sanofi 2015-08-30
NCT01539655 Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib https://ClinicalTrials.gov/show/NCT01539655 Completed Sanofi 2012-09-30
NCT04161391 Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations https://ClinicalTrials.gov/show/NCT04161391 Recruiting Turning Point Therapeutics, Inc. 2024-05-31
NCT02867592 Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors https://ClinicalTrials.gov/show/NCT02867592 Recruiting National Cancer Institute (NCI) 2020-09-30
NCT02568267 Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) https://ClinicalTrials.gov/show/NCT02568267 Recruiting Hoffmann-La Roche 2022-12-01
NCT03475953 A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors https://ClinicalTrials.gov/show/NCT03475953 Recruiting Institut Bergonié 2020-11-30
NCT03246659 Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC https://ClinicalTrials.gov/show/NCT03246659 Completed Azienda Ospedaliero, Universitaria Pisana 2018-11-30
NCT03239769 Compare the Aesthetic Effect of Different Thyroidectomies https://ClinicalTrials.gov/show/NCT03239769 Completed Beijing Cancer Hospital 2015-06-01
NCT02702388 A Phase 2 Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 mg Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile https://ClinicalTrials.gov/show/NCT02702388 Active, not recruiting Eisai Inc. 2019-12-12
NCT03866382 Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors https://ClinicalTrials.gov/show/NCT03866382 Recruiting National Cancer Institute (NCI) 2023-02-28
NCT02432274 Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma https://ClinicalTrials.gov/show/NCT02432274 Completed Eisai Inc. 2019-07-31
NCT03157128 Phase 1/2 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT03157128 Recruiting Loxo Oncology, Inc. 2022-03-31
NCT04137185 Clinical Study of rhTSH in the Treatment of Patients With Thyroid Cancer After Resection of Stage I/II https://ClinicalTrials.gov/show/NCT04137185 Recruiting Suzhou Zelgen Biopharmaceuticals Co.,Ltd 2020-06-30
NCT03669432 To Study the Impact of Radiation Treatment After Surgery in Patient With Locally Advanced Thyroid Cancer. https://ClinicalTrials.gov/show/NCT03669432 Recruiting Tata Memorial Hospital 2021-07-31
NCT00794053 The Usefulness of Staining Lymph Nodes During Operations for Cancer Thyroid in Detecting the Nodes That Have Cancer https://ClinicalTrials.gov/show/NCT00794053 Completed University of Alexandria 2008-12-31
NCT00784303 Evaluating the Safety and Efficacy of Oral Lenvatinib in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology https://ClinicalTrials.gov/show/NCT00784303 Completed Eisai Inc. 2011-04-11
NCT00754182 Subcuticular Suture Versus Synthetic Glue in Thyroidectomy Incision https://ClinicalTrials.gov/show/NCT00754182 Completed Azienda Ospedaliero-Universitaria di Modena 2010-05-31
NCT00729157 Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy https://ClinicalTrials.gov/show/NCT00729157 Completed National Cancer Institute (NCI) 2012-10-31
NCT00718770 A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression https://ClinicalTrials.gov/show/NCT00718770 Completed University of Colorado, Denver 2013-01-31
NCT00704730 Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT00704730 Active, not recruiting Exelixis 2011-10-31
NCT00673010 Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT00673010 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-03-31
NCT00668811 Sutent Adjunctive Treatment of Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT00668811 Completed Washington Hospital Center 2015-09-30
NCT00654238 Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer https://ClinicalTrials.gov/show/NCT00654238 Completed University of Pennsylvania 2010-12-31
NCT00625846 Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer https://ClinicalTrials.gov/show/NCT00625846 Completed National Cancer Institute (NCI) 2018-12-21
NCT00615537 Pilot Study on Laser Ablation of Symptomatic Benign Thyroid Masses https://ClinicalTrials.gov/show/NCT00615537 Completed BioTex, Inc. 2011-01-31
NCT00604318 Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer https://ClinicalTrials.gov/show/NCT00604318 Completed Copenhagen University Hospital at Herlev 2012-02-29
NCT00603941 A Phase 1/2 Dose Finding Study of an Experimental New Drug CS7017, an Oral PPARγ Agonist Taken by Mouth Twice Daily in Combination With Paclitaxel Chemotherapy https://ClinicalTrials.gov/show/NCT00603941 Completed Daiichi Sankyo, Inc. 2011-12-31
NCT00559949 Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine https://ClinicalTrials.gov/show/NCT00559949 Completed National Cancer Institute (NCI) 2016-08-31
NCT00537797 Accuracy of FDG-PET Scanning to Diagnose Malignant Thyroid Nodules https://ClinicalTrials.gov/show/NCT00537797 Completed Washington University School of Medicine 2011-09-30
NCT00537095 Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer https://ClinicalTrials.gov/show/NCT00537095 Active, not recruiting Sanofi 2009-12-31
NCT00519896 Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT00519896 Completed University of Washington 2015-05-31
NCT00514046 Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT00514046 Active, not recruiting National Institutes of Health Clinical Center (CC) 2019-12-10
NCT00510640 Thyroid Cancer and Sunitinib https://ClinicalTrials.gov/show/NCT00510640 Completed University Hospital, Bordeaux 2012-03-31
NCT00470496 Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00470496 Completed Roswell Park Cancer Institute 2011-10-28
NCT00467506 Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT00467506 Completed Nantes University Hospital 2011-01-31
NCT00451880 Study of XL281 in Adults With Solid Tumors https://ClinicalTrials.gov/show/NCT00451880 Completed Exelixis 2011-10-31
NCT00415233 High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT00415233 Active, not recruiting University College, London 2011-06-30
NCT00410761 An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT00410761 Active, not recruiting Sanofi 2009-07-31
NCT00405405 Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer https://ClinicalTrials.gov/show/NCT00405405 Completed Thomas Jefferson University 2010-06-30
NCT00400465 Is the Routine Pressure Dressing After Thyroidectomy Necessary? https://ClinicalTrials.gov/show/NCT00400465 Completed Khon Kaen University 2007-08-31
NCT00390325 Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT00390325 Active, not recruiting National Cancer Institute (NCI) 2017-01-30
NCT00389441 Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer https://ClinicalTrials.gov/show/NCT00389441 Completed Pfizer 2012-09-30
NCT00381641 Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT00381641 Active, not recruiting National Cancer Institute (NCI) 2016-12-31
NCT00358956 A Study To Assess ZD6474 (ZACTIMAâ„¢) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT00358956 Completed Sanofi 2008-01-31
NCT00295763 A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen. https://ClinicalTrials.gov/show/NCT00295763 Completed Sanofi 2006-07-31
NCT00287287 REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas https://ClinicalTrials.gov/show/NCT00287287 Completed University of Kentucky 2010-07-06
NCT00279721 Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer. https://ClinicalTrials.gov/show/NCT00279721 Completed AHS Cancer Control Alberta 2010-06-30
NCT00251316 Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer https://ClinicalTrials.gov/show/NCT00251316 Completed National Institutes of Health Clinical Center (CC) 2011-12-31
NCT00223158 Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer https://ClinicalTrials.gov/show/NCT00223158 Completed Université de Sherbrooke 2005-05-31
NCT00215605 Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies https://ClinicalTrials.gov/show/NCT00215605 Completed Exelixis 2011-04-30
NCT00196729 Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration https://ClinicalTrials.gov/show/NCT00196729 Completed Sanofi NA
NCT00181168 Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer https://ClinicalTrials.gov/show/NCT00181168 Completed Johns Hopkins University 2003-09-30
NCT00176748 Treatment for Patients With Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT00176748 Completed University of Michigan Rogel Cancer Center 2006-08-31
NCT00144079 Multicenter Study Differentiated Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT00144079 Completed University Hospital Muenster NA
NCT00134043 Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer https://ClinicalTrials.gov/show/NCT00134043 Completed National Cancer Institute (NCI) 2009-03-31
NCT00124527 Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer https://ClinicalTrials.gov/show/NCT00124527 Completed Eisai Inc. NA
NCT00123760 Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer https://ClinicalTrials.gov/show/NCT00123760 Completed AHS Cancer Control Alberta 2008-12-31
NCT00121628 A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT00121628 Completed Amgen 2006-11-30
NCT00118248 Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT00118248 Completed National Cancer Institute (NCI) 2009-08-31
NCT00115895 The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy https://ClinicalTrials.gov/show/NCT00115895 Active, not recruiting University of Helsinki 2004-10-31
NCT00104871 Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy https://ClinicalTrials.gov/show/NCT00104871 Completed National Cancer Institute (NCI) 2010-05-31
NCT00098813 Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine https://ClinicalTrials.gov/show/NCT00098813 Completed National Cancer Institute (NCI) 2009-08-31
NCT00098345 Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer https://ClinicalTrials.gov/show/NCT00098345 Completed Sanofi 2008-02-29
NCT00095836 Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy https://ClinicalTrials.gov/show/NCT00095836 Completed Massachusetts General Hospital 2011-03-31
NCT00094055 Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer https://ClinicalTrials.gov/show/NCT00094055 Completed Pfizer 2009-01-31
NCT00004089 Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer https://ClinicalTrials.gov/show/NCT00004089 Completed National Cancer Institute (NCI) 2002-04-30
NCT00085293 Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131 https://ClinicalTrials.gov/show/NCT00085293 Completed National Cancer Institute (NCI) 2014-01-31
NCT00004048 Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer https://ClinicalTrials.gov/show/NCT00004048 Completed Garden State Cancer Center at the Center for Molecular Medicine and Immunology 2002-05-31
NCT00080574 The Effect of Thyroid Hormone on Drug Elimination in Cancer Patients https://ClinicalTrials.gov/show/NCT00080574 Completed National Institutes of Health Clinical Center (CC) NA
NCT00004074 Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu https://ClinicalTrials.gov/show/NCT00004074 Completed National Cancer Institute (NCI) 2009-02-28
NCT00068497 Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00068497 Completed National Cancer Institute (NCI) 2007-12-31
NCT00795782 Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma https://ClinicalTrials.gov/show/NCT00795782 Completed Samsung Medical Center 2012-06-30
NCT00001730 Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal. https://ClinicalTrials.gov/show/NCT00001730 Completed National Institutes of Health Clinical Center (CC) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT01109420 Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01109420 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00342446 A Follow-up Study of Women Evaluated and Treated for Infertility https://ClinicalTrials.gov/show/NCT00342446 Completed National Institutes of Health Clinical Center (CC) NA
NCT04216732 Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management https://ClinicalTrials.gov/show/NCT04216732 Recruiting M.D. Anderson Cancer Center 2022-09-01
NCT03397238 Myeloid Cell Reprogramming in Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT03397238 Recruiting Radboud University 2020-06-30
NCT03392402 Molecular Classifier for the Fine Needle-based Assessment of Malignancy Risk in Thyroid Nodules https://ClinicalTrials.gov/show/NCT03392402 Recruiting Maria Sklodowska-Curie Institute - Oncology Center 2020-03-31
NCT03363347 BRAF V600E and Redifferentiation Therapy in Radioiodine-refractory Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT03363347 Completed Heidelberg University 2014-12-31
NCT03307694 Thyroid Ultrasound Elasticity (TrUE) Imaging https://ClinicalTrials.gov/show/NCT03307694 Completed Emory University 2018-07-13
NCT03300284 Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT03300284 Recruiting Memorial Sloan Kettering Cancer Center 2021-08-31
NCT03294005 Clinical Prediction Thyroid Cancer With Thyroid Ultrasonography https://ClinicalTrials.gov/show/NCT03294005 Active, not recruiting China Medical University Hospital 2019-06-26
NCT03271892 Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT03271892 Recruiting University Health Network, Toronto 2026-05-11
NCT03191643 PET-guided External Beam Radiotherapy in Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT03191643 Completed Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi 2016-01-31
NCT03160482 PACE4 in Thyroid Cancer https://ClinicalTrials.gov/show/NCT03160482 Completed Université de Sherbrooke 2018-01-15
NCT03105648 Diagnostic and Prognostic Significance of Computerized Cytologic Morphometry of the Thyroid Neoplasm https://ClinicalTrials.gov/show/NCT03105648 Recruiting National Taiwan University Hospital 2026-04-20
NCT02952612 Active Surveillance of Papillary Thyroid Microcarcinoma https://ClinicalTrials.gov/show/NCT02952612 Recruiting Seoul St. Mary’s Hospital 2017-10-31
NCT02938702 Active Surveillance on Papillary Thyroid Microcarcinoma https://ClinicalTrials.gov/show/NCT02938702 Active, not recruiting Seoul National University Hospital 2025-03-31
NCT02911155 Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists https://ClinicalTrials.gov/show/NCT02911155 Completed National Institutes of Health Clinical Center (CC) 2020-05-01
NCT02773667 Renal Tracer Elimination in Thyroid Cancer Patients Treated With 131-Iodine https://ClinicalTrials.gov/show/NCT02773667 Recruiting Jena University Hospital 2020-12-31
NCT02764554 Post-Marketing Surveillance of Lenvima in Korean Patients https://ClinicalTrials.gov/show/NCT02764554 Recruiting Eisai Inc. 2021-10-31
NCT02658513 Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer https://ClinicalTrials.gov/show/NCT02658513 Completed Royal Surrey County Hospital NHS Foundation Trust 2019-03-31
NCT01005654 Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms https://ClinicalTrials.gov/show/NCT01005654 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00001160 Studies on Tumors of the Thyroid https://ClinicalTrials.gov/show/NCT00001160 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01441154 Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment https://ClinicalTrials.gov/show/NCT01441154 Completed National Institutes of Health Clinical Center (CC) NA
NCT02465424 Assessing Quality of Life Tools in Medullary Thyroid Cancer Patients https://ClinicalTrials.gov/show/NCT02465424 Completed Velindre NHS Trust 2017-12-31
NCT02442661 Clinical Validation of a Predictive Model for the Presence of Cervical Lymph Node Metastasis in Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT02442661 Completed University of Colorado, Denver 2016-12-31
NCT02430714 Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T) https://ClinicalTrials.gov/show/NCT02430714 Completed Eisai Inc. 2016-11-06
NCT02375451 Effect of Childhood Radioiodine Therapy on Salivary Function https://ClinicalTrials.gov/show/NCT02375451 Completed Boston Children’s Hospital 2016-09-30
NCT02347683 Optimal Measurement of Thyroglobulin Measurement Following Thyroidectomy https://ClinicalTrials.gov/show/NCT02347683 Completed University of Nebraska 2016-02-29
NCT02323724 APPLICATION OF MOLECULAR TECHNIQUES FOR IMPROVING THE DIAGNOSIS AND TREATMENT OF NODULAR THYROID LESIONS. https://ClinicalTrials.gov/show/NCT02323724 Completed Corporacion Parc Tauli 2015-07-31
NCT02303444 An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors https://ClinicalTrials.gov/show/NCT02303444 Active, not recruiting Bayer 2020-07-08
NCT02194920 Parathyroid Reimplantation in Forearm Subcutaneous Tissue During Thyroidectomy: a Simple Way to Avoid Ipoparathyroidism and Evaluate Graft Function https://ClinicalTrials.gov/show/NCT02194920 Completed University of Roma La Sapienza 2014-10-31
NCT02185560 Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib https://ClinicalTrials.gov/show/NCT02185560 Active, not recruiting Bayer 2020-02-27
NCT01311089 A Comparative Study of Robotic Thyroidectomy Using Transaxillary Approach Versus Conventional Open Thyroidectomy https://ClinicalTrials.gov/show/NCT01311089 Completed Yonsei University 2011-09-30
NCT01954134 P53 in Differentiated Thyroid Cancer https://ClinicalTrials.gov/show/NCT01954134 Completed Cumhuriyet University 2013-01-31
NCT01945762 Observational Study to Evaluate Vandetanib in RET -/+ Patients With Metastatic Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01945762 Recruiting Sanofi 2019-09-30
NCT04396912 Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort https://ClinicalTrials.gov/show/NCT04396912 Recruiting Umraniye Education and Research Hospital 2021-06-01
NCT01792492 The Role of an Optical Probe in Thyroid Cancer Diagnosis: Pilot Study https://ClinicalTrials.gov/show/NCT01792492 Completed Boston Medical Center 2010-03-31
NCT01757470 Vandetanib Risk Minimisation Effectiveness https://ClinicalTrials.gov/show/NCT01757470 Completed Sanofi 2014-02-28
NCT01736163 A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 Tumours https://ClinicalTrials.gov/show/NCT01736163 Completed Sanofi 2012-08-31
NCT01690806 Dexamethasone for the Prevention of Recurrent Laryngeal Nerve Palsy https://ClinicalTrials.gov/show/NCT01690806 Completed Università degli Studi dell’Aquila 2012-01-31
NCT01659385 Leptin Levels in Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT01659385 Completed University of Nebraska 2013-06-30
NCT01648569 Long-term Outcomes of Total Thyroidectomy Versus Less Than Total Thyroidectomy for Papillary Thyroid Microcarcinoma https://ClinicalTrials.gov/show/NCT01648569 Completed Korean Association of Endocrine Surgeons 2012-05-31
NCT01586520 Diagnosing Thyroid Cancer Using a Blood Test https://ClinicalTrials.gov/show/NCT01586520 Completed Newcastle-upon-Tyne Hospitals NHS Trust 2014-10-31
NCT01487057 Lipid Metabolic Status in Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT01487057 Completed Prof. Dr. I. Chiricuta Institute of Oncology 2012-02-29
NCT01433809 Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm https://ClinicalTrials.gov/show/NCT01433809 Completed Mayo Clinic 2013-05-31
NCT01428167 Hashimotos Thyroiditis and Thyroid Cancer https://ClinicalTrials.gov/show/NCT01428167 Completed The University of Texas Medical Branch, Galveston 2012-05-31
NCT01424878 Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients https://ClinicalTrials.gov/show/NCT01424878 Completed National Institutes of Health Clinical Center (CC) NA
NCT01412762 Measuring Patient Expectations for Thyroid Surgery https://ClinicalTrials.gov/show/NCT01412762 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-07-31
NCT01392222 Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others https://ClinicalTrials.gov/show/NCT01392222 Completed Memorial Sloan Kettering Cancer Center 2017-06-30
NCT01384786 The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter https://ClinicalTrials.gov/show/NCT01384786 Completed Copenhagen University Hospital at Herlev NA
NCT01354639 Comparative Study of Surgical Completeness After Robotic Thyroidectomy Versus Conventional Open Thyroidectomy https://ClinicalTrials.gov/show/NCT01354639 Completed Yonsei University 2011-10-31
NCT04391244 Investigating National Solutions for Personalised Iodine-131 Radiation Exposure https://ClinicalTrials.gov/show/NCT04391244 Recruiting Royal Marsden NHS Foundation Trust 2022-07-31
NCT04339478 Does Parathyroid Autofluorescence Reduces Unintensional Parathyroidectomy During Total Thyroidectomy With Central Lymph Node Compartment Dissection https://ClinicalTrials.gov/show/NCT04339478 Recruiting Aristotle University Of Thessaloniki 2020-09-30
NCT04274829 Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid https://ClinicalTrials.gov/show/NCT04274829 Completed University of Cagliari 2018-01-31
NCT04139096 Genetic Susceptibility to Radiation Induced Thyroid Cancer https://ClinicalTrials.gov/show/NCT04139096 Recruiting Institut National de la Santé Et de la Recherche Médicale, France 2020-04-30
NCT04133870 Identification of Molecular Biomarkers for Thyroid Cancer https://ClinicalTrials.gov/show/NCT04133870 Active, not recruiting Royal Marsden NHS Foundation Trust 2018-04-30
NCT04076514 The Role of Central Neck Dissection in Stage N0 Papillary Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT04076514 Recruiting Assiut University 2020-09-30
NCT04072731 SREBP1 as a Potential Biomarker Promotes Cell Proliferation and Invasion in Thyroid Cancer https://ClinicalTrials.gov/show/NCT04072731 Completed People’s Hospital of Zhengzhou University 2017-07-30
NCT04031638 Thyroid Cancer Database https://ClinicalTrials.gov/show/NCT04031638 Recruiting Centre Georges Francois Leclerc 2025-01-01
NCT04031339 Study of Clinical Outcomes of Thyroid Cancer https://ClinicalTrials.gov/show/NCT04031339 Recruiting University of Roma La Sapienza 2025-01-31
NCT03986437 A Prospective Study to Collect Images in Patients Treated With Iodine-131 as Part of a European Research Project in Radiation Protection. https://ClinicalTrials.gov/show/NCT03986437 Recruiting Institut Claudius Regaud 2021-03-31
NCT03889769 Evaluation of Accuracy of One-Step Nucleic Acid Amplification (OSNA) in Diagnosis of Lymph Node Metastases of Papillary Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT03889769 Recruiting University of Cagliari 2019-04-01
NCT03787121 Estimation of Economic Consequences Linked With Different Care Management Pathways of Differentiated Thyroid Cancers https://ClinicalTrials.gov/show/NCT03787121 Recruiting University Hospital, Toulouse 2021-12-31
NCT03774862 Clinicopathological Importance of Colorectal Medullary Carcinoma: Retrospective Cohort Study https://ClinicalTrials.gov/show/NCT03774862 Completed V.K.V. American Hospital, Istanbul 2017-12-31
NCT03765333 GETNE Registration of Thyroid Cancer https://ClinicalTrials.gov/show/NCT03765333 Recruiting Grupo Espanol de Tumores Neuroendocrinos 2020-05-31
NCT03657654 Voice Outcomes Following Thyroidectomy https://ClinicalTrials.gov/show/NCT03657654 Recruiting University of Virginia 2020-07-15
NCT03624751 Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment https://ClinicalTrials.gov/show/NCT03624751 Recruiting Taichung Veterans General Hospital 2028-06-30
NCT03623516 Overdiagnosis of Thyroid Cancer in the Marne and Ardennes Departments of France From 1975 to 2014 https://ClinicalTrials.gov/show/NCT03623516 Completed CHU de Reims 2014-12-01
NCT03543891 Intestinal Microbiota and Thyroid Cancer https://ClinicalTrials.gov/show/NCT03543891 Completed First Affiliated Hospital of Harbin Medical University 2018-02-28
NCT03484884 A Study of Optical Imaging With Light From Radiotracers in Cancer Patients https://ClinicalTrials.gov/show/NCT03484884 Recruiting Memorial Sloan Kettering Cancer Center 2021-03-31
NCT01102127 Elastography in Thyroid Nodules https://ClinicalTrials.gov/show/NCT01102127 Completed Castilla-León Health Service 2010-09-30
NCT01089335 Sentinel Lymphnode in Patients With Papillary Thyroid Carcinoma and in Patients With Suspected Thyroid Neoplasia https://ClinicalTrials.gov/show/NCT01089335 Completed Region Skane 2018-12-31
NCT00880503 Collection of Tissue Samples for Study of Multidrug Resistance https://ClinicalTrials.gov/show/NCT00880503 Completed National Institutes of Health Clinical Center (CC) NA
NCT04411290 Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases https://ClinicalTrials.gov/show/NCT04411290 Enrolling by invitation Umraniye Education and Research Hospital 2021-06-01
NCT02645786 Thyrotropin Over-suppression and Heart https://ClinicalTrials.gov/show/NCT02645786 Completed Chuncheon Sacred Heart Hospital 2013-11-30
NCT00341094 Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Ukraine Following the Chernobyl Accident https://ClinicalTrials.gov/show/NCT00341094 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT03643055 18F-Fluorocholine PET/CT in Medullary Thyroid Cancer https://ClinicalTrials.gov/show/NCT03643055 Recruiting University Medical Centre Ljubljana 2020-09-03
NCT03285230 The French E3N Prospective Cohort Study https://ClinicalTrials.gov/show/NCT03285230 Active, not recruiting Institut National de la Santé Et de la Recherche Médicale, France 1991-11-15
NCT02178345 Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer https://ClinicalTrials.gov/show/NCT02178345 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-06-30
NCT03676348 HRQOL in Thyroid Cancer and Thyroid Tumours https://ClinicalTrials.gov/show/NCT03676348 Recruiting Oslo University Hospital 2023-01-31
NCT00719615 Assess Vitamin D Levels in Those With & Without Thyroid Cancer https://ClinicalTrials.gov/show/NCT00719615 Completed University of Nebraska 2009-03-31
NCT00571090 Prediction of Thyroid Cancer From Ultrasonographic Characteristics of Thyroid Nodules https://ClinicalTrials.gov/show/NCT00571090 Completed Istanbul Science University 2012-07-31
NCT00571077 Electrical Impedance Scanning of Thyroid Nodules Prior to Thyroid Surgery: a Prospective Study https://ClinicalTrials.gov/show/NCT00571077 Completed Hadassah Medical Organization NA
NCT00551486 Pyrosequencing of the BRAFV600E Mutation https://ClinicalTrials.gov/show/NCT00551486 Completed Chungnam National University NA
NCT00568438 Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample https://ClinicalTrials.gov/show/NCT00568438 Recruiting Stanford University 2020-04-30
NCT00480428 Radiation Exposure and Thyroid Disease in Kazakhstan https://ClinicalTrials.gov/show/NCT00480428 Completed National Institutes of Health Clinical Center (CC) NA
NCT00459498 Expression of NIS Protein and mRNA in Thyroid Tumors https://ClinicalTrials.gov/show/NCT00459498 Completed University of Sao Paulo NA
NCT00459459 Prognostic Significance of Fine-Needle Aspiration Cytology Features in Papillary Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT00459459 Completed National Taiwan University Hospital NA
NCT00454077 rhTSH-Thyroid Ablation With 1850 MBq of 131I https://ClinicalTrials.gov/show/NCT00454077 Completed University of Siena NA
NCT00439478 Dental Safety Profile of High-Dose Radioiodine Therapy https://ClinicalTrials.gov/show/NCT00439478 Completed University Hospital, Basel, Switzerland NA
NCT00439127 OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation https://ClinicalTrials.gov/show/NCT00439127 Completed Oncology Institute of Southern Switzerland NA
NCT00342641 Association Between Hepatitis C Virus Infection and Hematologic and Thyroid Cancers https://ClinicalTrials.gov/show/NCT00342641 Completed National Institutes of Health Clinical Center (CC) NA
NCT00342407 The Incidence of Breast and Other Cancers Among Female Flight Attendants https://ClinicalTrials.gov/show/NCT00342407 Completed National Institutes of Health Clinical Center (CC) 2005-12-31
NCT00341185 Studies of Thyroid Abnormalities in Northeastern Kazakhstan Associated With Nuclear Weapons Testing https://ClinicalTrials.gov/show/NCT00341185 Completed National Institutes of Health Clinical Center (CC) NA
NCT00339716 Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Belarus Following the Chernobyl Accident https://ClinicalTrials.gov/show/NCT00339716 Completed National Institutes of Health Clinical Center (CC) 2020-03-11
NCT00280852 Review of Multimodality Management of Anaplastic Thyroid Cancer https://ClinicalTrials.gov/show/NCT00280852 Completed AHS Cancer Control Alberta 2006-06-30
NCT00148213 Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma https://ClinicalTrials.gov/show/NCT00148213 Completed University Hospital Muenster NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03160274 Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions https://ClinicalTrials.gov/show/NCT03160274 Recruiting The University of Texas Health Science Center at San Antonio 2030-12-31
NCT03031639 Khon Kaen University’s Thyroidectomy Registry https://ClinicalTrials.gov/show/NCT03031639 Recruiting Khon Kaen University 2021-01-13
NCT02869620 Institut Paoli Calmettes Thyroid Cancer Database https://ClinicalTrials.gov/show/NCT02869620 Recruiting Institut Paoli-Calmettes 2030-01-31
NCT02862470 Anaplastic Thyroid Cancer and Follicular Thyroid Cancer-derived Exosomal Analysis Via Treatment of Lovastatin and Vildagliptin and Pilot Prognostic Study Via Urine Exosomal Biological Markers in Thyroid Cancer Patients https://ClinicalTrials.gov/show/NCT02862470 Active, not recruiting National Taiwan University Hospital 2018-10-31
NCT02012699 Integrated Cancer Repository for Cancer Research https://ClinicalTrials.gov/show/NCT02012699 Recruiting University of Nebraska 2099-12-31
NCT01511393 An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC) https://ClinicalTrials.gov/show/NCT01511393 Enrolling by invitation United BioSource, LLC 2035-12-31
NCT03488134 Predicting Prognosis and Recurrence of Thyroid Cancer Via New Biomarkers, Urinary Exosomal Thyroglobulin and Galectin-3 https://ClinicalTrials.gov/show/NCT03488134 Active, not recruiting National Taiwan University Hospital 2021-07-31
NCT01774279 interNational Anaplastic Thyroid Cancer Tissue Bank and Database (iNATT) https://ClinicalTrials.gov/show/NCT01774279 Recruiting Velindre NHS Trust 2022-02-28
NCT02109250 CAPRELSA® REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa®) in Current Clinical Practice https://ClinicalTrials.gov/show/NCT02109250 Completed Sanofi 2015-06-30
NCT00598364 Molecular Markers in Thyroid Cancer https://ClinicalTrials.gov/show/NCT00598364 Completed OHSU Knight Cancer Institute 2010-10-31